Cargando…

New Diagnostic Modality Combining Mass Spectrometry and Machine Learning for the Discrimination of Malignant Intraductal Papillary Mucinous Neoplasms

BACKGROUND: An intraductal papillary mucinous neoplasm (IPMN) is a pancreatic tumor with malignant potential. Although we anticipate a sensitive method to diagnose the malignant conversion of IPMN, an effective strategy has not yet been established. The combination of probe electrospray ionization-m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiritani, Sho, Iwano, Tomohiko, Yoshimura, Kentaro, Saito, Ryo, Nakayama, Takashi, Yamamoto, Daisuke, Hakoda, Hiroyuki, Watanabe, Genki, Akamatsu, Nobuhisa, Arita, Junichi, Kaneko, Junichi, Takeda, Sén, Ichikawa, Daisuke, Hasegawa, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085898/
https://www.ncbi.nlm.nih.gov/pubmed/36611070
http://dx.doi.org/10.1245/s10434-022-13012-y
_version_ 1785022026896900096
author Kiritani, Sho
Iwano, Tomohiko
Yoshimura, Kentaro
Saito, Ryo
Nakayama, Takashi
Yamamoto, Daisuke
Hakoda, Hiroyuki
Watanabe, Genki
Akamatsu, Nobuhisa
Arita, Junichi
Kaneko, Junichi
Takeda, Sén
Ichikawa, Daisuke
Hasegawa, Kiyoshi
author_facet Kiritani, Sho
Iwano, Tomohiko
Yoshimura, Kentaro
Saito, Ryo
Nakayama, Takashi
Yamamoto, Daisuke
Hakoda, Hiroyuki
Watanabe, Genki
Akamatsu, Nobuhisa
Arita, Junichi
Kaneko, Junichi
Takeda, Sén
Ichikawa, Daisuke
Hasegawa, Kiyoshi
author_sort Kiritani, Sho
collection PubMed
description BACKGROUND: An intraductal papillary mucinous neoplasm (IPMN) is a pancreatic tumor with malignant potential. Although we anticipate a sensitive method to diagnose the malignant conversion of IPMN, an effective strategy has not yet been established. The combination of probe electrospray ionization-mass spectrometry (PESI-MS) and machine learning provides a promising solution for this purpose. METHODS: We prospectively analyzed 42 serum samples obtained from IPMN patients who underwent pancreatic resection between 2020 and 2021. Based on the postoperative pathological diagnosis, patients were classified into two groups: IPMN-low grade dysplasia (n = 17) and advanced-IPMN (n = 25). Serum samples were analyzed by PESI-MS, and the obtained mass spectral data were converted into continuous variables. These variables were used to discriminate advanced-IPMN from IPMN-low grade dysplasia by partial least square regression or support vector machine analysis. The areas under receiver operating characteristics curves were obtained to visualize the difference between the two groups. RESULTS: Partial least square regression successfully discriminated the two disease classes. From another standpoint, we selected 130 parameters from the entire dataset by PESI-MS, which were fed into the support vector machine. The diagnostic accuracy was 88.1%, and the area under the receiver operating characteristics curve was 0.924 by this method. Approximately 10 min were required to perform each method. CONCLUSION: PESI-MS combined with machine learning is an easy-to-use tool with the advantage of rapid on-site analysis. Here, we show the great potential of our system to diagnose the malignant conversion of IPMN, which would be a promising diagnostic tool in clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-022-13012-y.
format Online
Article
Text
id pubmed-10085898
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-100858982023-04-12 New Diagnostic Modality Combining Mass Spectrometry and Machine Learning for the Discrimination of Malignant Intraductal Papillary Mucinous Neoplasms Kiritani, Sho Iwano, Tomohiko Yoshimura, Kentaro Saito, Ryo Nakayama, Takashi Yamamoto, Daisuke Hakoda, Hiroyuki Watanabe, Genki Akamatsu, Nobuhisa Arita, Junichi Kaneko, Junichi Takeda, Sén Ichikawa, Daisuke Hasegawa, Kiyoshi Ann Surg Oncol Translational Research BACKGROUND: An intraductal papillary mucinous neoplasm (IPMN) is a pancreatic tumor with malignant potential. Although we anticipate a sensitive method to diagnose the malignant conversion of IPMN, an effective strategy has not yet been established. The combination of probe electrospray ionization-mass spectrometry (PESI-MS) and machine learning provides a promising solution for this purpose. METHODS: We prospectively analyzed 42 serum samples obtained from IPMN patients who underwent pancreatic resection between 2020 and 2021. Based on the postoperative pathological diagnosis, patients were classified into two groups: IPMN-low grade dysplasia (n = 17) and advanced-IPMN (n = 25). Serum samples were analyzed by PESI-MS, and the obtained mass spectral data were converted into continuous variables. These variables were used to discriminate advanced-IPMN from IPMN-low grade dysplasia by partial least square regression or support vector machine analysis. The areas under receiver operating characteristics curves were obtained to visualize the difference between the two groups. RESULTS: Partial least square regression successfully discriminated the two disease classes. From another standpoint, we selected 130 parameters from the entire dataset by PESI-MS, which were fed into the support vector machine. The diagnostic accuracy was 88.1%, and the area under the receiver operating characteristics curve was 0.924 by this method. Approximately 10 min were required to perform each method. CONCLUSION: PESI-MS combined with machine learning is an easy-to-use tool with the advantage of rapid on-site analysis. Here, we show the great potential of our system to diagnose the malignant conversion of IPMN, which would be a promising diagnostic tool in clinical settings. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1245/s10434-022-13012-y. Springer International Publishing 2023-01-08 2023 /pmc/articles/PMC10085898/ /pubmed/36611070 http://dx.doi.org/10.1245/s10434-022-13012-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Translational Research
Kiritani, Sho
Iwano, Tomohiko
Yoshimura, Kentaro
Saito, Ryo
Nakayama, Takashi
Yamamoto, Daisuke
Hakoda, Hiroyuki
Watanabe, Genki
Akamatsu, Nobuhisa
Arita, Junichi
Kaneko, Junichi
Takeda, Sén
Ichikawa, Daisuke
Hasegawa, Kiyoshi
New Diagnostic Modality Combining Mass Spectrometry and Machine Learning for the Discrimination of Malignant Intraductal Papillary Mucinous Neoplasms
title New Diagnostic Modality Combining Mass Spectrometry and Machine Learning for the Discrimination of Malignant Intraductal Papillary Mucinous Neoplasms
title_full New Diagnostic Modality Combining Mass Spectrometry and Machine Learning for the Discrimination of Malignant Intraductal Papillary Mucinous Neoplasms
title_fullStr New Diagnostic Modality Combining Mass Spectrometry and Machine Learning for the Discrimination of Malignant Intraductal Papillary Mucinous Neoplasms
title_full_unstemmed New Diagnostic Modality Combining Mass Spectrometry and Machine Learning for the Discrimination of Malignant Intraductal Papillary Mucinous Neoplasms
title_short New Diagnostic Modality Combining Mass Spectrometry and Machine Learning for the Discrimination of Malignant Intraductal Papillary Mucinous Neoplasms
title_sort new diagnostic modality combining mass spectrometry and machine learning for the discrimination of malignant intraductal papillary mucinous neoplasms
topic Translational Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085898/
https://www.ncbi.nlm.nih.gov/pubmed/36611070
http://dx.doi.org/10.1245/s10434-022-13012-y
work_keys_str_mv AT kiritanisho newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT iwanotomohiko newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT yoshimurakentaro newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT saitoryo newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT nakayamatakashi newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT yamamotodaisuke newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT hakodahiroyuki newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT watanabegenki newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT akamatsunobuhisa newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT aritajunichi newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT kanekojunichi newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT takedasen newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT ichikawadaisuke newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms
AT hasegawakiyoshi newdiagnosticmodalitycombiningmassspectrometryandmachinelearningforthediscriminationofmalignantintraductalpapillarymucinousneoplasms